ArticleMolecular cancer therapeutics2022

Acquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype.

Samuel E J Preston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.